6-methyl-1,3,8-trichlorodibenzofuran has been researched along with 3,3'-diindolylmethane in 2 studies
| Studies (6-methyl-1,3,8-trichlorodibenzofuran) | Trials (6-methyl-1,3,8-trichlorodibenzofuran) | Recent Studies (post-2010) (6-methyl-1,3,8-trichlorodibenzofuran) | Studies (3,3'-diindolylmethane) | Trials (3,3'-diindolylmethane) | Recent Studies (post-2010) (3,3'-diindolylmethane) |
|---|---|---|---|---|---|
| 25 | 0 | 3 | 409 | 16 | 252 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballarotto, M; Dolciami, D; Fallarino, F; Gargaro, M; López-Cara, LC; Macchiarulo, A | 1 |
| Abdelrahim, M; Ariazi, E; Jordan, VC; Khan, S; Liu, S; Safe, S | 1 |
1 review(s) available for 6-methyl-1,3,8-trichlorodibenzofuran and 3,3'-diindolylmethane
| Article | Year |
|---|---|
Targeting Aryl hydrocarbon receptor for next-generation immunotherapies: Selective modulators (SAhRMs) versus rapidly metabolized ligands (RMAhRLs).
Topics: Animals; Humans; Immune System Diseases; Immunotherapy; Ligands; Molecular Structure; Receptors, Aryl Hydrocarbon | 2020 |
1 other study(ies) available for 6-methyl-1,3,8-trichlorodibenzofuran and 3,3'-diindolylmethane
| Article | Year |
|---|---|
Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cells.
Topics: Benzo(a)pyrene; Benzofurans; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Estrogen Receptor alpha; Flavonoids; Humans; Indoles; Ligands; Methylcholanthrene; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Presenilin-2; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; Structure-Activity Relationship | 2006 |